Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lyme Disease | 47 | 2024 | 631 | 11.840 |
Why?
|
Meningitis, Bacterial | 35 | 2024 | 222 | 7.160 |
Why?
|
Head Injuries, Closed | 7 | 2019 | 133 | 3.000 |
Why?
|
Spinal Puncture | 15 | 2020 | 284 | 2.620 |
Why?
|
Serologic Tests | 9 | 2024 | 382 | 2.520 |
Why?
|
Emergency Service, Hospital | 59 | 2024 | 7875 | 2.400 |
Why?
|
Diabetic Ketoacidosis | 13 | 2023 | 253 | 2.400 |
Why?
|
Fever | 22 | 2024 | 1603 | 2.340 |
Why?
|
Immunoenzyme Techniques | 7 | 2021 | 1701 | 2.180 |
Why?
|
Bacterial Infections | 11 | 2024 | 1387 | 2.070 |
Why?
|
Meningitis, Aseptic | 9 | 2013 | 59 | 2.020 |
Why?
|
Cerebrospinal Fluid Shunts | 5 | 2018 | 199 | 1.870 |
Why?
|
Bacteremia | 14 | 2024 | 989 | 1.700 |
Why?
|
Meningitis | 7 | 2023 | 216 | 1.600 |
Why?
|
Decision Support Techniques | 13 | 2019 | 2003 | 1.520 |
Why?
|
Meningitis, Viral | 6 | 2017 | 49 | 1.500 |
Why?
|
Cerebrospinal Fluid | 14 | 2021 | 539 | 1.420 |
Why?
|
Arthritis, Infectious | 7 | 2024 | 345 | 1.370 |
Why?
|
Borrelia burgdorferi | 8 | 2024 | 184 | 1.360 |
Why?
|
Lyme Neuroborreliosis | 5 | 2020 | 50 | 1.360 |
Why?
|
Child | 119 | 2024 | 80564 | 1.330 |
Why?
|
Wounds, Nonpenetrating | 7 | 2015 | 807 | 1.270 |
Why?
|
Infant | 93 | 2024 | 36386 | 1.250 |
Why?
|
Endemic Diseases | 6 | 2024 | 189 | 1.230 |
Why?
|
Leukocyte Count | 14 | 2024 | 1602 | 1.220 |
Why?
|
Polymerase Chain Reaction | 11 | 2019 | 6069 | 1.190 |
Why?
|
Facial Paralysis | 4 | 2017 | 346 | 1.140 |
Why?
|
Synovial Fluid | 4 | 2024 | 385 | 1.120 |
Why?
|
Skull Fractures | 4 | 2020 | 202 | 1.120 |
Why?
|
Leukocytosis | 10 | 2021 | 248 | 1.110 |
Why?
|
Fluid Therapy | 9 | 2023 | 584 | 1.090 |
Why?
|
Immunoblotting | 3 | 2019 | 1644 | 1.060 |
Why?
|
Sensitivity and Specificity | 33 | 2024 | 14652 | 1.040 |
Why?
|
Erythema Chronicum Migrans | 2 | 2023 | 50 | 1.040 |
Why?
|
Enterovirus | 4 | 2017 | 69 | 0.970 |
Why?
|
Child, Preschool | 63 | 2024 | 42500 | 0.960 |
Why?
|
Enterovirus Infections | 5 | 2017 | 74 | 0.950 |
Why?
|
Brain Injuries | 7 | 2022 | 2060 | 0.930 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 7478 | 0.930 |
Why?
|
Ceftriaxone | 4 | 2023 | 176 | 0.900 |
Why?
|
Antibodies, Bacterial | 8 | 2024 | 1476 | 0.890 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.850 |
Why?
|
Craniocerebral Trauma | 6 | 2020 | 494 | 0.840 |
Why?
|
Immunoglobulin M | 6 | 2024 | 1528 | 0.820 |
Why?
|
Tomography, X-Ray Computed | 18 | 2020 | 20659 | 0.820 |
Why?
|
Cerebrospinal Fluid Proteins | 5 | 2018 | 71 | 0.790 |
Why?
|
Adolescent | 72 | 2024 | 88835 | 0.770 |
Why?
|
Ondansetron | 2 | 2020 | 95 | 0.750 |
Why?
|
Bicycling | 2 | 2014 | 176 | 0.750 |
Why?
|
Accidents, Traffic | 4 | 2015 | 818 | 0.710 |
Why?
|
Ixodes | 1 | 2020 | 41 | 0.710 |
Why?
|
Antiemetics | 2 | 2020 | 185 | 0.700 |
Why?
|
Doxycycline | 2 | 2023 | 349 | 0.690 |
Why?
|
Herpes Simplex | 6 | 2022 | 472 | 0.680 |
Why?
|
Clinical Enzyme Tests | 1 | 2019 | 114 | 0.670 |
Why?
|
Retrospective Studies | 78 | 2024 | 81514 | 0.660 |
Why?
|
Pediatrics | 10 | 2024 | 3606 | 0.640 |
Why?
|
Complement C6 | 1 | 2018 | 12 | 0.640 |
Why?
|
Infant, Newborn | 47 | 2022 | 26346 | 0.640 |
Why?
|
Otitis Media | 2 | 2020 | 287 | 0.640 |
Why?
|
Skull | 2 | 2015 | 811 | 0.620 |
Why?
|
Humans | 192 | 2024 | 765968 | 0.620 |
Why?
|
Diagnosis, Differential | 19 | 2022 | 12976 | 0.600 |
Why?
|
Herpes Zoster Oticus | 1 | 2017 | 7 | 0.590 |
Why?
|
Hospitals, Pediatric | 11 | 2019 | 1846 | 0.590 |
Why?
|
Glasgow Coma Scale | 7 | 2021 | 575 | 0.580 |
Why?
|
Hospitalization | 14 | 2021 | 10808 | 0.580 |
Why?
|
Urinary Tract Infections | 7 | 2022 | 805 | 0.580 |
Why?
|
Emergency Medicine | 4 | 2021 | 1221 | 0.560 |
Why?
|
Multi-Institutional Systems | 1 | 2017 | 43 | 0.560 |
Why?
|
Facial Nerve Injuries | 1 | 2017 | 64 | 0.550 |
Why?
|
Cross-Sectional Studies | 37 | 2023 | 26318 | 0.550 |
Why?
|
Male | 112 | 2024 | 363698 | 0.540 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3850 | 0.530 |
Why?
|
Bibliometrics | 1 | 2020 | 357 | 0.530 |
Why?
|
Female | 114 | 2024 | 396112 | 0.520 |
Why?
|
Publishing | 2 | 2020 | 835 | 0.520 |
Why?
|
Simplexvirus | 4 | 2022 | 807 | 0.500 |
Why?
|
Knee Joint | 3 | 2022 | 1656 | 0.490 |
Why?
|
Bacteria | 6 | 2022 | 2209 | 0.480 |
Why?
|
Emergency Treatment | 4 | 2021 | 494 | 0.470 |
Why?
|
Accidental Falls | 2 | 2014 | 1078 | 0.470 |
Why?
|
Prospective Studies | 27 | 2023 | 54802 | 0.470 |
Why?
|
Rheumatology | 5 | 2021 | 602 | 0.460 |
Why?
|
Hydrocephalus | 3 | 2018 | 762 | 0.460 |
Why?
|
Nursing Diagnosis | 1 | 2013 | 16 | 0.440 |
Why?
|
Physician-Nurse Relations | 1 | 2013 | 20 | 0.440 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1462 | 0.420 |
Why?
|
Advisory Committees | 1 | 2017 | 796 | 0.410 |
Why?
|
Mental Recall | 1 | 2019 | 1218 | 0.400 |
Why?
|
Quality Improvement | 3 | 2017 | 3853 | 0.400 |
Why?
|
Clinical Medicine | 1 | 2013 | 145 | 0.390 |
Why?
|
Cervical Vertebrae | 4 | 2013 | 974 | 0.390 |
Why?
|
Trauma Severity Indices | 5 | 2015 | 479 | 0.380 |
Why?
|
Spinal Injuries | 2 | 2012 | 301 | 0.380 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.380 |
Why?
|
Hip Joint | 1 | 2018 | 1000 | 0.370 |
Why?
|
Neutrophils | 5 | 2024 | 3776 | 0.360 |
Why?
|
Cohort Studies | 25 | 2023 | 41649 | 0.340 |
Why?
|
Arthropod Vectors | 1 | 2008 | 6 | 0.310 |
Why?
|
Research | 1 | 2017 | 1975 | 0.300 |
Why?
|
Emergencies | 3 | 2021 | 1223 | 0.300 |
Why?
|
Glucose | 5 | 2023 | 4335 | 0.300 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3807 | 0.300 |
Why?
|
Tularemia | 1 | 2008 | 40 | 0.300 |
Why?
|
Parents | 3 | 2019 | 3592 | 0.300 |
Why?
|
Blood Cell Count | 4 | 2019 | 405 | 0.300 |
Why?
|
Tick-Borne Diseases | 1 | 2008 | 37 | 0.300 |
Why?
|
Blood Sedimentation | 2 | 2019 | 233 | 0.300 |
Why?
|
Child Abuse | 1 | 2017 | 1090 | 0.300 |
Why?
|
Francisella tularensis | 1 | 2008 | 60 | 0.300 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 747 | 0.290 |
Why?
|
Emergency Medical Services | 4 | 2021 | 1938 | 0.290 |
Why?
|
Pneumococcal Vaccines | 2 | 2008 | 414 | 0.280 |
Why?
|
False Negative Reactions | 2 | 2020 | 573 | 0.280 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15398 | 0.280 |
Why?
|
Lyme Disease Vaccines | 1 | 2006 | 18 | 0.270 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 400 | 0.270 |
Why?
|
Insulin | 1 | 2021 | 6599 | 0.270 |
Why?
|
Heart Ventricles | 1 | 2018 | 3832 | 0.260 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4528 | 0.260 |
Why?
|
Erythrocytes | 3 | 2017 | 2395 | 0.260 |
Why?
|
Boston | 8 | 2019 | 9338 | 0.260 |
Why?
|
Status Epilepticus | 3 | 2017 | 460 | 0.260 |
Why?
|
Vomiting | 2 | 2020 | 647 | 0.260 |
Why?
|
Central Nervous System Viral Diseases | 2 | 2018 | 39 | 0.260 |
Why?
|
Thrombocytosis | 1 | 2006 | 87 | 0.250 |
Why?
|
Guideline Adherence | 2 | 2015 | 2243 | 0.250 |
Why?
|
United States | 31 | 2024 | 72903 | 0.250 |
Why?
|
Skin Pigmentation | 1 | 2007 | 279 | 0.250 |
Why?
|
Clinical Competence | 2 | 2018 | 4863 | 0.240 |
Why?
|
Young Adult | 21 | 2024 | 59889 | 0.240 |
Why?
|
Labor, Obstetric | 1 | 2007 | 317 | 0.230 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5891 | 0.230 |
Why?
|
Equipment Failure | 2 | 2018 | 578 | 0.230 |
Why?
|
Neurology | 3 | 2021 | 785 | 0.230 |
Why?
|
Health Services Research | 3 | 2021 | 1808 | 0.230 |
Why?
|
Risk Factors | 23 | 2024 | 74840 | 0.230 |
Why?
|
False Positive Reactions | 2 | 2016 | 955 | 0.220 |
Why?
|
Length of Stay | 6 | 2019 | 6485 | 0.220 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15880 | 0.210 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 527 | 0.210 |
Why?
|
Myocarditis | 2 | 2021 | 802 | 0.210 |
Why?
|
Family | 2 | 2019 | 3209 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3446 | 0.210 |
Why?
|
Urinalysis | 6 | 2022 | 368 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 238 | 0.210 |
Why?
|
Pyuria | 1 | 2022 | 30 | 0.200 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.200 |
Why?
|
Communicable Diseases | 2 | 2021 | 874 | 0.200 |
Why?
|
Infusions, Intravenous | 3 | 2023 | 2229 | 0.200 |
Why?
|
Reproducibility of Results | 12 | 2020 | 20124 | 0.190 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2006 | 374 | 0.190 |
Why?
|
Erythrocyte Count | 2 | 2020 | 158 | 0.190 |
Why?
|
ROC Curve | 6 | 2024 | 3620 | 0.190 |
Why?
|
Pneumonia | 2 | 2023 | 2157 | 0.190 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2006 | 537 | 0.180 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7425 | 0.180 |
Why?
|
Radiography | 1 | 2012 | 6919 | 0.180 |
Why?
|
Oxadiazoles | 1 | 2001 | 94 | 0.180 |
Why?
|
Rotavirus Infections | 1 | 2002 | 85 | 0.180 |
Why?
|
Rotavirus | 1 | 2002 | 110 | 0.180 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 946 | 0.170 |
Why?
|
Societies, Medical | 3 | 2020 | 3956 | 0.170 |
Why?
|
Risk Assessment | 9 | 2021 | 24282 | 0.170 |
Why?
|
Lymphadenitis | 1 | 2020 | 98 | 0.170 |
Why?
|
Brain Concussion | 3 | 2017 | 1432 | 0.170 |
Why?
|
Cerebellar Diseases | 1 | 2002 | 226 | 0.160 |
Why?
|
Biomedical Research | 3 | 2020 | 3458 | 0.160 |
Why?
|
Brain Edema | 2 | 2021 | 602 | 0.160 |
Why?
|
Congresses as Topic | 2 | 2024 | 811 | 0.160 |
Why?
|
Acidosis | 1 | 2021 | 271 | 0.160 |
Why?
|
Algorithms | 6 | 2024 | 14071 | 0.160 |
Why?
|
Sodium | 2 | 2021 | 1591 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2022 | 1946 | 0.160 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2007 | 1022 | 0.160 |
Why?
|
Blood Glucose | 2 | 2023 | 6424 | 0.160 |
Why?
|
Borrelia | 1 | 2019 | 66 | 0.160 |
Why?
|
Bacteriuria | 1 | 2019 | 102 | 0.160 |
Why?
|
Delphi Technique | 2 | 2020 | 893 | 0.160 |
Why?
|
Medical Errors | 1 | 2007 | 1260 | 0.150 |
Why?
|
Rehydration Solutions | 1 | 2018 | 44 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 408 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2018 | 39193 | 0.150 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2019 | 113 | 0.150 |
Why?
|
Pakistan | 1 | 2018 | 300 | 0.140 |
Why?
|
Judgment | 1 | 2019 | 270 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 2 | 2019 | 1175 | 0.140 |
Why?
|
Scalp | 1 | 2020 | 388 | 0.140 |
Why?
|
Ticks | 2 | 2008 | 72 | 0.140 |
Why?
|
Multivariate Analysis | 8 | 2012 | 12056 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2015 | 2352 | 0.140 |
Why?
|
Financing, Organized | 1 | 2019 | 201 | 0.140 |
Why?
|
Encephalitis, Viral | 1 | 2017 | 59 | 0.140 |
Why?
|
Incidence | 9 | 2018 | 21480 | 0.140 |
Why?
|
Peer Review | 1 | 2019 | 217 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2016 | 790 | 0.140 |
Why?
|
Age Factors | 9 | 2021 | 18380 | 0.140 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2418 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2021 | 896 | 0.140 |
Why?
|
Antiviral Agents | 2 | 2017 | 3050 | 0.140 |
Why?
|
Seizures | 3 | 2021 | 3000 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3685 | 0.130 |
Why?
|
Prevalence | 4 | 2022 | 15842 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 598 | 0.130 |
Why?
|
Authorship | 1 | 2019 | 288 | 0.130 |
Why?
|
International Cooperation | 2 | 2021 | 1432 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 586 | 0.130 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 239 | 0.120 |
Why?
|
Hematoma | 1 | 2020 | 766 | 0.120 |
Why?
|
Trauma Centers | 2 | 2011 | 952 | 0.120 |
Why?
|
Seat Belts | 1 | 2015 | 60 | 0.120 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2015 | 67 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1114 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 36532 | 0.120 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 339 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 786 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2016 | 234 | 0.120 |
Why?
|
International Classification of Diseases | 3 | 2015 | 935 | 0.120 |
Why?
|
Editorial Policies | 1 | 2019 | 458 | 0.120 |
Why?
|
Nurse Practitioners | 2 | 2018 | 272 | 0.110 |
Why?
|
Time Factors | 9 | 2020 | 40065 | 0.110 |
Why?
|
Abscess | 1 | 2018 | 606 | 0.110 |
Why?
|
Vulnerable Populations | 1 | 2019 | 718 | 0.110 |
Why?
|
Cell Count | 1 | 2018 | 1823 | 0.110 |
Why?
|
Confidence Intervals | 4 | 2012 | 2910 | 0.110 |
Why?
|
Education, Nursing, Diploma Programs | 1 | 2013 | 11 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2015 | 2778 | 0.110 |
Why?
|
Physical Examination | 1 | 2020 | 1266 | 0.110 |
Why?
|
Acute Disease | 3 | 2019 | 7232 | 0.110 |
Why?
|
Head | 1 | 2019 | 925 | 0.110 |
Why?
|
Databases, Factual | 5 | 2019 | 8067 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 714 | 0.100 |
Why?
|
Child Restraint Systems | 1 | 2012 | 20 | 0.100 |
Why?
|
Ataxia | 1 | 2014 | 307 | 0.100 |
Why?
|
Parenting | 1 | 2018 | 709 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2022 | 22223 | 0.100 |
Why?
|
Cognition | 3 | 2023 | 7049 | 0.100 |
Why?
|
Drainage | 1 | 2018 | 1179 | 0.100 |
Why?
|
Blood Proteins | 1 | 2017 | 1188 | 0.100 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 162 | 0.100 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 814 | 0.100 |
Why?
|
Hospital Costs | 2 | 2013 | 956 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8703 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1316 | 0.100 |
Why?
|
Absenteeism | 1 | 2013 | 246 | 0.090 |
Why?
|
Italy | 1 | 2014 | 854 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2013 | 508 | 0.090 |
Why?
|
Hypertension | 2 | 2023 | 8626 | 0.090 |
Why?
|
Statistics, Nonparametric | 3 | 2016 | 2844 | 0.090 |
Why?
|
Gentian Violet | 2 | 2019 | 25 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2001 | 1759 | 0.090 |
Why?
|
Phenazines | 2 | 2019 | 53 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2199 | 0.090 |
Why?
|
Cranial Nerve Diseases | 1 | 2011 | 111 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2499 | 0.090 |
Why?
|
Caustics | 1 | 2001 | 33 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1978 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1275 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1060 | 0.090 |
Why?
|
Hair Preparations | 1 | 2001 | 33 | 0.090 |
Why?
|
Brain | 2 | 2014 | 27171 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1455 | 0.090 |
Why?
|
Time | 1 | 2012 | 550 | 0.090 |
Why?
|
Schools | 2 | 2023 | 1492 | 0.090 |
Why?
|
Neurosurgical Procedures | 2 | 2019 | 2074 | 0.090 |
Why?
|
Post-Concussion Syndrome | 1 | 2013 | 257 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4015 | 0.080 |
Why?
|
Cost-Benefit Analysis | 2 | 2019 | 5526 | 0.080 |
Why?
|
Esophageal Diseases | 1 | 2001 | 166 | 0.080 |
Why?
|
Pharyngeal Diseases | 1 | 2001 | 133 | 0.080 |
Why?
|
Patient Discharge | 3 | 2021 | 3461 | 0.080 |
Why?
|
Erythema | 1 | 2001 | 262 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 279 | 0.080 |
Why?
|
Brazil | 1 | 2013 | 1248 | 0.080 |
Why?
|
Electronic Health Records | 4 | 2024 | 4873 | 0.080 |
Why?
|
Whooping Cough | 1 | 2010 | 87 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 493 | 0.080 |
Why?
|
Logistic Models | 6 | 2019 | 13266 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4300 | 0.080 |
Why?
|
Patient Care | 1 | 2014 | 629 | 0.080 |
Why?
|
Linear Models | 3 | 2017 | 5876 | 0.080 |
Why?
|
Haemophilus influenzae type b | 1 | 2008 | 16 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1880 | 0.080 |
Why?
|
Diptera | 1 | 2008 | 51 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 540 | 0.080 |
Why?
|
Meningitis, Meningococcal | 1 | 2008 | 43 | 0.070 |
Why?
|
Haemophilus Infections | 1 | 2008 | 93 | 0.070 |
Why?
|
Rest | 1 | 2013 | 942 | 0.070 |
Why?
|
Disease Reservoirs | 1 | 2008 | 124 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2172 | 0.070 |
Why?
|
Neisseria meningitidis | 1 | 2008 | 111 | 0.070 |
Why?
|
Treatment Failure | 1 | 2014 | 2652 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2015 | 1181 | 0.070 |
Why?
|
Sodium Chloride | 2 | 2021 | 576 | 0.070 |
Why?
|
Bioterrorism | 1 | 2008 | 144 | 0.070 |
Why?
|
Laryngeal Diseases | 1 | 2001 | 248 | 0.070 |
Why?
|
Immunoassay | 2 | 2024 | 741 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2017 | 2511 | 0.070 |
Why?
|
Hyperbilirubinemia | 1 | 2007 | 74 | 0.070 |
Why?
|
Zoonoses | 1 | 2008 | 181 | 0.070 |
Why?
|
Massachusetts | 5 | 2015 | 8875 | 0.070 |
Why?
|
Decision Making | 3 | 2014 | 3965 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2615 | 0.070 |
Why?
|
North America | 2 | 2021 | 1285 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2019 | 2187 | 0.070 |
Why?
|
Adult | 12 | 2024 | 223044 | 0.070 |
Why?
|
Rodentia | 1 | 2008 | 261 | 0.070 |
Why?
|
Cough | 1 | 2001 | 597 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2015 | 1944 | 0.070 |
Why?
|
Odds Ratio | 5 | 2021 | 9649 | 0.070 |
Why?
|
Health Resources | 1 | 2013 | 949 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8041 | 0.070 |
Why?
|
Respiratory Sounds | 1 | 2001 | 705 | 0.070 |
Why?
|
Borrelia burgdorferi Group | 1 | 2006 | 97 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6544 | 0.070 |
Why?
|
RNA | 1 | 2016 | 2717 | 0.070 |
Why?
|
Anaphylaxis | 1 | 2013 | 739 | 0.070 |
Why?
|
Injury Severity Score | 3 | 2017 | 1050 | 0.060 |
Why?
|
Education, Medical | 1 | 2018 | 1746 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2013 | 927 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 65188 | 0.060 |
Why?
|
Consensus | 3 | 2020 | 3202 | 0.060 |
Why?
|
Leukocytes | 1 | 2014 | 2027 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2699 | 0.060 |
Why?
|
Latex Fixation Tests | 1 | 2004 | 29 | 0.060 |
Why?
|
Mid-Atlantic Region | 1 | 2024 | 24 | 0.060 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2011 | 1019 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8532 | 0.060 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 1303 | 0.060 |
Why?
|
Prognosis | 6 | 2020 | 29922 | 0.060 |
Why?
|
Maryland | 1 | 2024 | 278 | 0.050 |
Why?
|
Arthritis, Psoriatic | 1 | 2006 | 216 | 0.050 |
Why?
|
Primary Health Care | 2 | 2017 | 4736 | 0.050 |
Why?
|
Headache | 1 | 2011 | 1259 | 0.050 |
Why?
|
Mass Media | 1 | 2006 | 301 | 0.050 |
Why?
|
Platelet Count | 1 | 2006 | 782 | 0.050 |
Why?
|
Medical Records | 2 | 2019 | 1409 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4058 | 0.050 |
Why?
|
Canada | 2 | 2020 | 2119 | 0.050 |
Why?
|
Survival Analysis | 2 | 2012 | 10070 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2006 | 993 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2013 | 1240 | 0.050 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1543 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 762 | 0.050 |
Why?
|
Public Opinion | 1 | 2006 | 482 | 0.050 |
Why?
|
Seasons | 1 | 2008 | 1524 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2022 | 189 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9347 | 0.050 |
Why?
|
Internship and Residency | 2 | 2020 | 5946 | 0.050 |
Why?
|
Dehydration | 1 | 2023 | 215 | 0.050 |
Why?
|
Virginia | 1 | 2021 | 115 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1660 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13462 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 18 | 0.050 |
Why?
|
Scotland | 1 | 2001 | 115 | 0.050 |
Why?
|
Romania | 1 | 2001 | 97 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4850 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2606 | 0.040 |
Why?
|
Animals | 5 | 2021 | 168764 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 51 | 0.040 |
Why?
|
Electrolytes | 1 | 2021 | 280 | 0.040 |
Why?
|
Drug Industry | 1 | 2006 | 791 | 0.040 |
Why?
|
Area Under Curve | 2 | 2017 | 1638 | 0.040 |
Why?
|
Communicable Diseases, Emerging | 1 | 2021 | 150 | 0.040 |
Why?
|
Oxazoles | 1 | 2001 | 198 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2020 | 504 | 0.040 |
Why?
|
Atrioventricular Block | 1 | 2021 | 141 | 0.040 |
Why?
|
Spain | 1 | 2020 | 483 | 0.040 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1135 | 0.040 |
Why?
|
Chlorides | 1 | 2021 | 666 | 0.040 |
Why?
|
Body Temperature | 1 | 2021 | 779 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 552 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 404 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3888 | 0.040 |
Why?
|
Middle Aged | 5 | 2024 | 223009 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1377 | 0.030 |
Why?
|
Registries | 2 | 2011 | 8297 | 0.030 |
Why?
|
Age Distribution | 2 | 2013 | 2858 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 502 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 881 | 0.030 |
Why?
|
Population Surveillance | 1 | 2007 | 2590 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2024 | 2354 | 0.030 |
Why?
|
Escherichia coli | 1 | 2008 | 4214 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 2021 | 1146 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 574 | 0.030 |
Why?
|
Cost Savings | 1 | 2000 | 904 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2023 | 1219 | 0.030 |
Why?
|
Trust | 1 | 2019 | 533 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1187 | 0.030 |
Why?
|
Health Literacy | 1 | 2019 | 464 | 0.030 |
Why?
|
Vaccination | 1 | 2006 | 3426 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2233 | 0.030 |
Why?
|
Law Enforcement | 1 | 2015 | 112 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3318 | 0.030 |
Why?
|
Proteins | 1 | 2008 | 5995 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1171 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 752 | 0.030 |
Why?
|
RNA, Viral | 1 | 2002 | 2864 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2013 | 2721 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 433 | 0.030 |
Why?
|
Ultrasonography | 1 | 2006 | 5993 | 0.030 |
Why?
|
Cost Control | 1 | 2015 | 624 | 0.020 |
Why?
|
Anxiety | 1 | 2007 | 4671 | 0.020 |
Why?
|
Overweight | 1 | 2023 | 2444 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3230 | 0.020 |
Why?
|
Mental Disorders | 1 | 2012 | 6853 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2017 | 1187 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1393 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2122 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.020 |
Why?
|
Program Development | 1 | 2017 | 1295 | 0.020 |
Why?
|
Health Care Costs | 2 | 2015 | 3242 | 0.020 |
Why?
|
Accidents, Home | 1 | 2001 | 73 | 0.020 |
Why?
|
Educational Measurement | 1 | 2018 | 1260 | 0.020 |
Why?
|
Memory | 1 | 2020 | 2190 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4908 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 671 | 0.020 |
Why?
|
Product Labeling | 1 | 2001 | 75 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2601 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 59489 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171117 | 0.020 |
Why?
|
Accidents | 1 | 2010 | 164 | 0.020 |
Why?
|
Health Promotion | 1 | 2021 | 2208 | 0.020 |
Why?
|
Physicians | 2 | 2018 | 4588 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2263 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 358 | 0.020 |
Why?
|
Movement Disorders | 1 | 2012 | 461 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6404 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16721 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1806 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2424 | 0.020 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2001 | 418 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3286 | 0.020 |
Why?
|
Device Removal | 1 | 2012 | 646 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8501 | 0.020 |
Why?
|
Video Recording | 1 | 2012 | 969 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2017 | 1944 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2012 | 781 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 30260 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2001 | 686 | 0.020 |
Why?
|
Computer Systems | 1 | 2007 | 466 | 0.020 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 340 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1672 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2016 | 5302 | 0.010 |
Why?
|
Curriculum | 1 | 2018 | 3782 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2012 | 1002 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7838 | 0.010 |
Why?
|
Dexamethasone | 1 | 2001 | 1963 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2966 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9591 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8733 | 0.010 |
Why?
|
Mass Screening | 1 | 2018 | 5446 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6203 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1326 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3708 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4294 | 0.010 |
Why?
|
Information Dissemination | 1 | 2010 | 1142 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2001 | 1808 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7123 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14751 | 0.010 |
Why?
|
Age of Onset | 1 | 2006 | 3344 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2012 | 1732 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8923 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8529 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5343 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12509 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3320 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13632 | 0.010 |
Why?
|